InMed Pharmaceuticals financial statements

인메드 파머슈티컬스NASDAQ:INM · Nasdaq · Healthcare · sector #17
$1.33+0.00%
2026-10-06 close

InMed Pharmaceuticals's published financial data is dated 2026-10-04. 2025 revenue was $5M. 2025 operating profit was −$8M.

Reported results

InMed Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q